Table 2 Factors Affecting Complete Eradication of Dysplasia
All Patientsa | Complete Eradication of Dysplasia | Incomplete Eradication of Dysplasia | |||||
|---|---|---|---|---|---|---|---|
107 | 100.0% | 82 | 76.6% | 25 | 23.4% | p-valueb | |
Patient Characteristics | |||||||
Race | |||||||
White | 103 | 96.3% | 80 | 97.6% | 23 | 92.0% | 0.232 |
Other | 4 | 3.7% | 2 | 2.4% | 2 | 8.0% | |
Sex | |||||||
Male | 93 | 86.9% | 69 | 84.1% | 24 | 96.0% | 0.180 |
Female | 14 | 13.1% | 13 | 15.9% | 1 | 4.0% | |
Age | c64 | (58-72) | c 64 | (57–72) | c 66 | (59–76) | 0.336 |
BMI | c 29.1 | (25.5–32.6) | c 30.5 | (26.5–33.1) | c 27.45 | (24.5–30) | 0.045 |
Dysplasia | |||||||
HGD | 44 | 41.1% | 30 | 36.6% | 14 | 56.0% | 0.084 |
LGD | 63 | 58.9% | 52 | 63.4% | 11 | 44.0% | |
Comorbidities | 0.0% | ||||||
GERD | 75 | 70.1% | 60 | 73.2% | 15 | 60.0% | 0.208 |
Hyperlipidemia | 26 | 24.3% | 20 | 24.4% | 6 | 24.0% | 0.968 |
Diabetes | 25 | 23.4% | 18 | 22.0% | 7 | 28.0% | 0.532 |
Hypertension | 59 | 55.1% | 40 | 48.8% | 19 | 76.0% | 0.017 |
History of Tobacco Usage | |||||||
Yes | 60 | 56.1% | 43 | 52.4% | 17 | 68.0% | 0.350 |
No | 33 | 30.8% | 28 | 34.1% | 5 | 20.0% | |
Unknown | 14 | 13.1% | 11 | 13.4% | 3 | 12.0% | |
Endoscopic Treatments Received | |||||||
EMR | 24 | 22.4% | 18 | 22.0% | 6 | 24.0% | 0.732 |
Length | |||||||
Median, IQR | 5 | (2–7) | 4 | (2–7) | 6 | (2–8) | 0.150 |
</= 5 cm | 64 | 59.8% | 52 | 63.4% | 12 | 48.0% | 0.038 |
> 5 cm | 43 | 40.2% | 30 | 36.6% | 13 | 52.0% | |
Number of RFA’s | |||||||
Median, IQR | 3 | (2–5) | 3 | (2–5) | 4 | (2–5) | 0.066 |
≤ 3 | 62 | 57.9% | 52 | 63.4% | 10 | 40.0% | 0.064 |
> 3 | 45 | 42.1% | 30 | 36.6% | 15 | 60.0% | |